Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.

Not Applicable

Withdrawn

• Conditions: Vulvar Cancer

• Registration Number: NCT00382330
• Lead Sponsor: University of Medicine and Dentistry of New Jersey

Brief Summary

The purpose of this study is to determine if regular and daily repeated application of the ciclopirox lotion to vulva will make the precancerous lesion(s) shrink or even disappear.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-09-27
• Study First Submitted QC: 2006-09-27
• Study First Posted: 2006-09-29
• Status Verified: 2013-04
• Last Update Submitted: 2013-09-05
• Last Update Posted: 2013-09-06

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• Patients between the ages 18 and 75 years.
• Patients may be carriers of the Human Immunodeficiency Virus (HIV).
• Patients must have been diagnosed with precancerous lesion(s) of the vulva by tissue sampling (biopsy-proven vulvar intraepithelial neoplasia grade II or III)
• Patients must be able to come to University Hospital for their initial appointment in Gynecologic Oncology Clinic, and for the eight follow-up visits in that Clinic required by the protocol.

Exclusion Criteria

• Pregnant or patients who are breast feeding a baby.
• Patients who have been diagnosed with a vaginal yeast infection.
• Patients who have undergone prior surgery for precancerous lesion(s) of the vulva.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

University of Medicine and Dentistry of NJ; 🇺🇸 Newark, New Jersey, United States